Patient Reported Outcome study of Dapagliflozin on glycemic control and treatment satisfaction in overweight patients with type 2 diabetes mellitus

Trial Profile

Patient Reported Outcome study of Dapagliflozin on glycemic control and treatment satisfaction in overweight patients with type 2 diabetes mellitus

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Nov 2017

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Overweight; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms PRO
  • Most Recent Events

    • 24 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 30 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 28 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top